Skip to content
10-K

Annual Report

Natus Medical Inc

0000878526-21-000020

← back to feed
Filed
Feb 26, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Feb 19, 2021 33.87M sh
Long Term Debt FY 2020 · Dec 31, 2019 $19.67M
Current Liabilities FY 2020 · Dec 31, 2019 $142.82M
Total Liabilities FY 2020 · Dec 31, 2019 $206.4M
Current Assets FY 2020 · Dec 31, 2019 $269.75M
Total Assets FY 2020 · Dec 31, 2019 $622.53M
Shares Diluted FY 2020 · Dec 31, 2018 33.11M sh
Stock Repurchased FY 2020 · Dec 31, 2018 $5.63M
Capex FY 2020 · Dec 31, 2018 $7.88M
Operating Cash Flow FY 2020 · Dec 31, 2018 $33.02M
Eps Diluted FY 2020 · Dec 31, 2018 −$0.69
Eps Basic FY 2020 · Dec 31, 2018 −$0.69
Sga Expense FY 2020 · Dec 31, 2018 $70.6M
Rd Expense FY 2020 · Dec 31, 2018 $61.48M
Net Income FY 2020 · Dec 31, 2018 −$22.94M
Operating Income FY 2020 · Dec 31, 2018 −$24.56M
Gross Profit FY 2020 · Dec 31, 2018 $304.02M
Revenue FY 2020 · Dec 31, 2018 $530.89M
Cash And Equivalents FY 2020 · Dec 31, 2017 $88.95M
Stockholders Equity FY 2020 · Dec 31, 2017 $422.1M